Josefin Ahnström/LinkedIn; Christina Crossette-Thambiah/ profiles.imperial.ac.uk
May 29, 2026, 04:37
Josefin Ahnström: How Andexanet Alfa Impacts TFPIα Function
Josefin Ahnström, Associate Professor in Haematology at Imperial College London, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
”I am happy to share our most recent paper, published in Blood Advances, where we have investigated how Andexanet alfa impacts TFPI alpha function.
Amazing work Christina Crossette-Thambiah!
Thank you for all heart and hard work you’ve put into this project.”
Title: TFPIα inhibition by Andexanet alfa is partially restored by protein S and factor V-short
Authors: Christina Keshini Crossette-Thambiah, Krister Bamberg, Mike A Laffan, Josefin Ahnstrom
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 29, 2026, 15:09Abdulbari Mohammed: The Basics of Antiphospholipid Syndrome
-
Aug 29, 2026, 15:06Laurent Arnaud: Rare SLE Manifestations Demand More Than Rare Attention – Insights from The Lancet Rheumatology
-
Aug 29, 2026, 14:55Marco Vitolo: The Changing Landscape of Sex Differences in AF-Related Stroke
-
Aug 29, 2026, 14:54Hiteshi K.C. Chauhan: Should Patients with AF and Intermediate Stroke Risk Receive Anticoagulation?
-
Aug 29, 2026, 14:39C. Michael Gibson: SINGLE-AF Trial Supports DOAC Use in Intermediate-Risk Atrial Fibrillation
-
Aug 29, 2026, 14:07Vincent Rizzo: Beta Blocker Choice May Impact Portal Vein Thrombosis and Survival in Cirrhosis
-
Aug 29, 2026, 14:04Günalp Uzun: DGTI 2026 New Insights in Platelet Immunology and Hemostasis
-
Aug 29, 2026, 13:59Eleftheria Hatzimichael: ASH 2026 Guidelines for Primary ITP What Is Changing
-
Aug 29, 2026, 11:03Richard Davis: Navigating Acute PE – ESC vs. the New AHA/ACC Guidelines